FingerprintDive into the research topics of 'Phase II, open-label study of brivanib as first-line therapy in patients with advanced hepatocellular carcinoma'. Together they form a unique fingerprint.
- Sort by
Joong Won Park, Richard S. Finn, Jun Suk Kim, Mark Karwal, Ruby K. Li, Fuad Ismail, Melanie Thomas, Rosemarie Harris, Christine Baudelet, Ian Walters, Jean Luc Raoul
Research output: Contribution to journal › Article › peer-review